Company news

Amgen Inc. news in 2026

Amgen Inc.'s news releases, calls and decks from 2026, newest first.

View company

Repatha® cuts risk of first major cardiovascular events by 31% in high-risk patients without known significant atherosclerosis

March 27, 2026

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

March 12, 2026

Amgen to present at the leerink partners 2026 global healthcare conference

March 4, 2026

Amgen announces 2026 second quarter dividend

March 3, 2026

Amgen to present at the 46th annual td cowen health care conference

February 24, 2026

Matterworks, Inc. announces update to leadership team

February 17, 2026

Amgen to present at citi's 2026 virtual oncology leadership summit

February 13, 2026

BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration

February 5, 2026

Amgen reports fourth quarter and full year 2025 financial results

February 3, 2026

Amgen announces webcast of 2025 fourth quarter and full year financial results

January 28, 2026

Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference

January 21, 2026

Ember LifeSciences appoints Ann Hyllengren as Chief Financial Officer

January 21, 2026

Ro announces research collaboration to better understand and improve the real-world patient experience with glp-1S

January 13, 2026

Amgen to present at the 44th annual j.p. morgan healthcare conference

January 7, 2026

Amgen acquires Dark Blue Therapeutics, bolstering oncology pipeline

January 5, 2026

← Newer news releases

Calls in 2026

Decks in 2026